Dr. Grossbard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
240 East 38th Street
19th Floor
New York, NY 10016Phone+1 646-501-9305Fax+1 212-731-5540
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1992
- Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1989
- Yale School of MedicineClass of 1986
- Harvard CollegeAB, Biology, Summa Cum Laude, 1982
Certifications & Licensure
- NY State Medical License 1999 - 2025
- FL State Medical License 2021 - 2023
- MA State Medical License 1989 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2003-2019
- America's Top Doctors Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2002-2014
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 62 citationsMetastatic Pancreatic Cancer: Emerging Strategies in Chemotherapy and Palliative CareFrancois G. El Kamar, Michael L. Grossbard, Peter Kozuch
The Oncologist. 2003-02-01 - 116 citationsPrimary Systemic Therapy of Breast CancerIrina Sachelarie, Michael L. Grossbard, Manjeet Chadha, Sheldon Feldman, Munir Ghesani
The Oncologist. 2006-06-01 - 53 citationsInduction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: A phase I and II studyCameron D. Wright, John C. Wain, Thomas J. Lynch, Noah C. Choi, Michael L. Grossbard
The Journal of Thoracic and Cardiovascular Surgery. 1997-11-01
Journal Articles
- Nodular Lymphocyte Predominant Hodgkin Lymphoma: Biology, Diagnosis and TreatmentGoel A, Fan W, Patel AA, Devabahktuni M, Grossbard, ML, Clin Lymphoma, Myeloma, Leuk, 1/1/2014
- Impact of oncology drug shortages on patient therapy: unplanned treatment changesBecker DJ, Talwar S, Levy BP, Thorn M, Roitman J, Blum RH, Harrison LB, Grossbard ML, J Oncol Practice, 1/1/2013
- Phiase I study of Oxaliplatin in combination with Gemcitabine, Irinotecan, and 5-Fluorouracil/Leuconvorin (G-FLIE) in patirnts with metastatic solid tumors including a...Olszewski AJ, Grossbard ML, Chung MS, Chalasani SB, Malamud S, Mirzoyev T, Kozuch PS, J Gastrointest Cancer, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Evaluation of the Functional Landscape of Systemic Immunity in Classical Hodgkin Using a Novel Single Cell Platform (Isolight)Michael L. Grossbard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- KRAS mutations and outcomes for patients with stage IV NSCLC treated with frontline platinum/pemetrexed based chemotherapy.Levy B, Seetharamu N, Richardson S, Becker DJ, Choi W, Evans A, Bhora FY, Connery CP, Grossbard ML, Chachoua A, J Clin Oncol, 1/1/2012
- Impact of oncology drug shortages on patient treatment.Becker DJ, Talwar S, Levy B, Thorn M, Roitman J, Blum RH, Harrison LB, Grossbard ML, J Clin Oncol, 1/1/2012
Lectures
- Medical Grand Rounds: "Indolent Lymphoma: Concept to a Cure"New York University - 1/1/2014
- Grand Rounds: "Indolent Lymphoma: New Therapy Paradigms"Yale Cancer Center-, New Haven, CT - 1/1/2013
- "Frequently Asked Questions in Lymphoma" Panel DiscussionNew York - 1/1/2013
- Join now to see all
Other
- Empowering targeted therapy: Lessons from Rituximab.Olszewki AJ, Grossbard ML, Science STKE (Electronic Resource)
7/13/2004 - Malignant Lymphomas. Canada: BC Decker, Inc. (Editor)Grossbard ML
1/1/2001 - Dose-adjusted EPOCH chemotherapy and rituximab (R-EPOCH): An effective regimen in poor pognosis aggressive B-cell non-Hodgkin's lymphoma.Gutierrez ME, Grossbard M, Jaffe E, Chabner BA, Wilson WH, Monographs in Lymphoma; Physicians Education Resource
1/1/2000 - Join now to see all
Press Mentions
- Perlmutter Cancer Center Appoints Inaugural Director of Center for Blood CancersJanuary 24th, 2022
- Covid-19 and Cancer: Registry Data Suggest Cancer Tx Won’t Increase MortalityJuly 7th, 2020
- The Untold TollApril 17th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: